IMXI
International Money Express, Inc.
IMXI trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over IMXI overall, supported by stronger modeled upside and stronger fundamentals.
IMXI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Strong |
IMXI's cash flow and balance sheet are currently healthy, and its profitability is stable, but its revenue is under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
IMXI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.4x | $6.39 | — |
| Cheap | 11x | $6.63 | +3.8% |
| Current | 11x | $6.39 | — |
| Fair | 15x | $8.92 | +40% |
| Expensive | 19x | $11.18 | +75% |
Historical ranges are pointers, not guarantees.
IMXI's PE is in its cheap range at 11x. On analysts' estimates for next year's earnings, today's price would be 7.4x.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over IMXI in the historical PE scenario, which offers more potential upside but is not a forecast.
IMXI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect IMXI's earnings and revenue to decline, with profitability weakening.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
NVDA has the edge over IMXI on the outlook, with more favorable earnings and revenue expectations.
IMXI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.86 | +46% |
| Q3 2026 | $0.59 | -54% |
| Q2 2026 | $0.62 | -62% |
| Q1 2026 | $0.85 | -50% |
| Q4 2025 | $1.08 | -40% |
| Q3 2025 | $1.28 | -28% |
| Q2 2025 | $1.64 | -1.8% |
| Q1 2025 | $1.69 | +1.2% |
| Q4 2024 | $1.79 | +9.8% |
IMXI's earnings per share have fallen from their peak: $0.59 over the past year, against $1.79 in late 2024.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over IMXI on earnings, with more consistent year-over-year improvement.
IMXI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $126.4M | -18% |
| Q2 2026 | $131.2M | -19% |
| Q1 2026 | $122M | -15% |
| Q4 2025 | $147.4M | -11% |
| Q3 2025 | $154.9M | -9.9% |
| Q2 2025 | $161.1M | -6.1% |
| Q1 2025 | $144.3M | -4.1% |
| Q4 2024 | $164.8M | -4.1% |
IMXI's revenue has slid since its 2023 peak: $126M last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +0.4 points |
| Q2 2026 | 6.7% | -5.4 points |
| Q1 2026 | 3% | -6.7 points |
| Q4 2025 | 7.8% | -7.1 points |
| Q3 2025 | 6.8% | -9.4 points |
| Q2 2025 | 12% | -1.3 points |
| Q1 2025 | 9.8% | -3.3 points |
| Q4 2024 | 15% | -1.1 points |
IMXI's operating margin was 7.2% last quarter, about level with the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over IMXI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over IMXI on profitability, with a higher operating margin.
IMXI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.3M | +$38.8M |
| Q2 2026 | $107.2M | +203% |
| Q1 2026 | -$42.9M | -219% |
| Q4 2025 | -$20M | -$11.2M |
| Q3 2025 | -$35.5M | -252% |
| Q2 2025 | $35.3M | +$61.6M |
| Q1 2025 | $36M | +3.6% |
| Q4 2024 | -$8.8M | -116% |
IMXI still generates free cash flow, though less than at its 2026 peak: $48M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over IMXI on cash flow, with more consistent year-over-year improvement.
IMXI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +49.2K shares |
| 1 year | +2.8% | +841K shares |
| 3 years | -15% | -5.4M shares |
| 5 years | -22% | -8.7M shares |
| Available history | -20% | -7.6M shares |
IMXI has 31M diluted shares, up 2.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $11.4M |
| Q1 2025 | $5M |
| Q4 2024 | $20.2M |
IMXI hasn't bought back shares in the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over IMXI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
IMXI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | 0.2x | Very low |
IMXI has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
IMXI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.9 | Oversold |
| Stochastic | 7.3 | Oversold |
IMXI's weekly RSI is 22 (oversold) and its Stochastic is 7 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
IMXI PE vs Technology Sector
| Metric | IMXI | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 14 | 35 | 21 pts below |
IMXI has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
IMXI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.74 | 34% below |
| 20 week MA | $12.1 | 47% below |
| 50 week MA | $14.1 | 55% below |
| 100 week MA | $14.1 | 55% below |
| 200 week MA | $17.6 | 64% below |
IMXI is in a downtrend: it's below all five of its weekly moving averages, and 64% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over IMXI on trend strength, trading above more of its moving averages.
IMXI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.0 | $15.9 | +32% |
| 2021 | $15.9 | $15.8 | -0.6% |
| 2022 | $15.8 | $22.5 | +43% |
| 2023 | $22.5 | $22.1 | -1.6% |
| 2024 | $22.1 | $20.6 | -6.6% |
| 2025 | $20.6 | $15.4 | -25% |
| 2026 YTD | $15.4 | $6.39 | -59% |
IMXI has finished three years in a row lower, and it's down 59% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over IMXI on returns for 2026, with the stronger performance.